Analysts at UBS Kept their Past ‘”Buy”’ rating on Shares Mallinckrodt (NYSE:MNK), Set a $70.0 Price Objective

December 7, 2017 - By Richard Conner

 Analysts at UBS Kept their Past ‘

Investors sentiment decreased to 0.72 in 2017 Q2. Its down 0.30, from 1.02 in 2017Q1. It dropped, as 49 investors sold Mallinckrodt Public Limited Company shares while 136 reduced holdings. 37 funds opened positions while 96 raised stakes. 95.02 million shares or 0.42% more from 94.62 million shares in 2017Q1 were reported.

Endurant Management Lp reported 39,575 shares. Susquehanna Group Limited Liability Partnership accumulated 9,000 shares or 0% of the stock. Schwab Charles Invest Management holds 0.02% or 405,655 shares in its portfolio. Commerzbank Aktiengesellschaft Fi reported 57,894 shares stake. Quantbot Techs L P reported 9,441 shares or 0.04% of all its holdings. Ameritas Investment Partners has invested 0.01% in Mallinckrodt Public Limited Company (NYSE:MNK). Brandywine Ltd Limited Liability Company owns 1.15 million shares or 0.33% of their US portfolio. Amp Cap Investors Limited accumulated 184,590 shares. 22,260 were reported by Zurcher Kantonalbank (Zurich Cantonalbank). 14,330 are owned by Hancock Holding. Citadel Advsrs Limited Liability Co holds 2.71 million shares or 0.1% of its portfolio. X Mgmt Company Limited Company reported 1,019 shares or 0% of all its holdings. State Street owns 5.06M shares. Livforsakringsbolaget Skandia Omsesidigt owns 2,000 shares for 0.01% of their portfolio. Hanson Mcclain has 0% invested in Mallinckrodt Public Limited Company (NYSE:MNK).

Mallinckrodt (NYSE:MNK) Rating Reaffirmed

UBS now has a $70.0 target price on the $2.02 billion market cap company or 229.41 % upside potential. In an analyst report issued on Friday morning, Mallinckrodt (NYSE:MNK) shares have had their “Buy” Rating reiterated by expert analysts at UBS.

Investors sentiment decreased to 0.72 in 2017 Q2. Its down 0.30, from 1.02 in 2017Q1. It dropped, as 49 investors sold Mallinckrodt Public Limited Company shares while 136 reduced holdings. 37 funds opened positions while 96 raised stakes. 95.02 million shares or 0.42% more from 94.62 million shares in 2017Q1 were reported.

Endurant Management Lp reported 39,575 shares. Susquehanna Group Limited Liability Partnership accumulated 9,000 shares or 0% of the stock. Schwab Charles Invest Management holds 0.02% or 405,655 shares in its portfolio. Commerzbank Aktiengesellschaft Fi reported 57,894 shares stake. Quantbot Techs L P reported 9,441 shares or 0.04% of all its holdings. Ameritas Investment Partners has invested 0.01% in Mallinckrodt Public Limited Company (NYSE:MNK). Brandywine Ltd Limited Liability Company owns 1.15 million shares or 0.33% of their US portfolio. Amp Cap Investors Limited accumulated 184,590 shares. 22,260 were reported by Zurcher Kantonalbank (Zurich Cantonalbank). 14,330 are owned by Hancock Holding. Citadel Advsrs Limited Liability Co holds 2.71 million shares or 0.1% of its portfolio. X Mgmt Company Limited Company reported 1,019 shares or 0% of all its holdings. State Street owns 5.06M shares. Livforsakringsbolaget Skandia Omsesidigt owns 2,000 shares for 0.01% of their portfolio. Hanson Mcclain has 0% invested in Mallinckrodt Public Limited Company (NYSE:MNK).

Mallinckrodt Public Limited Company (NYSE:MNK) Ratings Coverage

Among 21 analysts covering Mallinckrodt (NYSE:MNK), 9 have Buy rating, 0 Sell and 12 Hold. Therefore 43% are positive. Mallinckrodt has $218 highest and $24.0 lowest target. $69.42’s average target is 226.68% above currents $21.25 stock price. Mallinckrodt had 86 analyst reports since August 5, 2015 according to SRatingsIntel. The stock has “Neutral” rating by JP Morgan on Wednesday, August 5. On Wednesday, November 8 the stock rating was downgraded by Goldman Sachs to “Neutral”. The stock of Mallinckrodt Public Limited Company (NYSE:MNK) has “Hold” rating given on Monday, October 23 by Mizuho. The rating was initiated by Northland Capital with “Outperform” on Wednesday, October 14. The firm has “Buy” rating given on Thursday, July 21 by Mizuho. Jefferies maintained the stock with “Buy” rating in Thursday, June 29 report. The stock has “Equal-Weight” rating by Barclays Capital on Wednesday, November 8. The firm earned “Buy” rating on Wednesday, August 9 by UBS. Mizuho initiated the shares of MNK in report on Friday, October 9 with “Neutral” rating. The rating was maintained by Jefferies with “Buy” on Wednesday, August 2.

The stock decreased 0.47% or $0.1 during the last trading session, reaching $21.25. About 2.24 million shares traded. Mallinckrodt Public Limited Company (NYSE:MNK) has declined 30.39% since December 7, 2016 and is downtrending. It has underperformed by 47.09% the S&P500.

Mallinckrodt public limited company develops, makes, markets, and distributes branded and generic specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. The company has market cap of $2.02 billion. The companyÂ’s Specialty Brands segment markets branded pharmaceutical products for autoimmune and rare diseases, including the specialty areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and hemostasis products, and central nervous system drugs. It currently has negative earnings. This segment offers Acthar, an injectable drug for various indications, such as neurology, rheumatology, nephrology, and pulmonology; Ofirmev, an intravenous formulation of acetaminophen for pain management; Inomax for inhalation; Therakos, an immunotherapy treatment platform; and Exalgo, a form of hydromorphone.

More notable recent Mallinckrodt Public Limited Company (NYSE:MNK) news were published by: Prnewswire.com which released: “Mallinckrodt plc Presents Health Economic Data on OFIRMEV® (acetaminophen …” on November 16, 2017, also Streetinsider.com with their article: “Wells Fargo Downgrades Mallinckrodt plc (MNK) to Market Perform” published on November 08, 2017, Seekingalpha.com published: “Insiders Of Mallinckrodt Just Bought $1.4 Million Worth Of Stock” on December 05, 2017. More interesting news about Mallinckrodt Public Limited Company (NYSE:MNK) were released by: Seekingalpha.com and their article: “Why Mallinckrodt Cratered” published on November 13, 2017 as well as Streetinsider.com‘s news article titled: “Mallinckrodt plc (MNK) PT Lowered to $40 at Piper Jaffray” with publication date: November 08, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.